Biol Reprod Lalor Postdoctoral Fellowships -- Application Deadline January 15, 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butcher, L.
Right arrow Articles by Leese, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butcher, L.
Right arrow Articles by Leese, H. J.
Agricola
Right arrow Articles by Butcher, L.
Right arrow Articles by Leese, H. J.

Biology of Reproduction, Vol 58, 1054-1056, Copyright © 1998 by Society for the Study of Reproduction

ARTICLES

Metabolism of pyruvate by the early human embryo

L Butcher, A Coates, KL Martin, AJ Rutherford and HJ Leese
Department of Biology, University of York, United Kingdom.

Pyruvate is added to all media used for human in vitro fertilization and embryo culture, but its function(s) in the early embryo is unknown. We tested the possibility that pyruvate can act as an oxidizable energy source by measuring the consumption of pyruvate and oxygen by Day 2 and Day 3 human embryos, using microfluorometric techniques. Oxygen consumption (19.6 pmol/embryo per hour) could account for the oxidation of only 56% of the pyruvate consumed (13.9 pmol/embryo per hour). Oxygen was also consumed in the absence of exogenous substrates. Lactate appeared in the incubation medium with pyruvate (0.47 mM) as sole exogenous substrate at a rate of 12.1 pmol/embryo per hour, at a similar rate (10.85 pmol/embryo per hour) in the presence of 1 mM glucose and 0.47 mM pyruvate, and at 2.25 pmol/embryo per hour in the absence of exogenous substrates, suggesting that a high proportion of the pyruvate taken up by early human embryos is converted to lactate. Pyruvate uptake in the presence of UK5099, a pyruvate transport inhibitor, was reduced to 10% of control values, consistent with the presence of the monocarboxylate carrier in the human embryo plasma membrane.


This article has been cited by other articles:


Home page
 Biol. Reprod.Home page
S. Jansen, M. Pantaleon, and P. L Kaye
Characterization and Regulation of Monocarboxylate Cotransporters Slc16a7 and Slc16a3 in Preimplantation Mouse Embryos
Biol Reprod, July 1, 2008; 79(1): 84 - 92.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
F. D Houghton
Role of gap junctions during early embryo development
Reproduction, February 1, 2005; 129(2): 129 - 135.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Roberts, S. Franks, and K. Hardy
Culture environment modulates maturation and metabolism of human oocytes
Hum. Reprod., November 1, 2002; 17(11): 2950 - 2956.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society for the Study of Reproduction.